Ebola Watch (DRC): The WHO says the new Ebola outbreak in the Democratic Republic of Congo is already hard to contain, with more than 500 cases and 130 deaths reported as the emergency was declared in mid-May—raising fears of wider spread and longer duration. CAR-T Deal (Germany): T-CURX is acquiring Pantherna Therapeutics to strengthen in-vivo CAR-T clinical validation, combining Pantherna’s mRNA engineering and lipid nanoparticle delivery know-how with T-CURX’s CAR-T platform. Cancer Research (ASCO): New trial readouts highlighted at ASCO include Immatics’ PRAME cell-therapy progress and BioNTech/BMS bispecific results in advanced lung cancer, pointing to faster-moving targeted treatment options. Healthcare Access (Rare cancers, Europe): A survey presented at ASCO suggests rare cancer patients in Europe face heavier treatment access burdens—longer travel, more fragmented care, and lower specialist visibility—especially in Germany. Public Health Risk (Hantavirus): An American cruise passenger exposed to hantavirus says he will stay in quarantine for the full 42 days, underscoring the long incubation period and the pressure on outbreak containment. AI & Safety (Policy): A draft federal AI strategy aims to scale adoption and expand AI literacy by 2031, while reporting also warns that people over-trust AI outputs despite frequent errors. Local Health Workforce (Germany): Germany’s healthcare staff are protesting proposed cuts, as unions warn staffing and care quality could take a hit.